Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer Meeting Abstract

  

Authors:	Schoenfeld, A. J.; Altan, M.; Owonikoko, T. K.; D'Angelo, S.; Ladle, B. H.; Noujaim, J.; He, K.; Liebner, D.; Sacher, A. G.; Haanen, J. B. A. G.; Yachnin, J.; Huang, C.; Van Tine, B. A.; Hasan, A.; Faitg, T.; Butler, E.; Shalabi, A.; Attia, S.; Araujo, D. M.
Abstract Title:	Master protocol to assess the safety and recommended Phase 2 dose of next generation NY-ESO-1-specific TCR T-cells in HLA-A*02 patients with synovial sarcoma and non-small cell lung cancer
Meeting Title:	112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	81
Issue:	13 Suppl.
Meeting Dates:	2021 Apr 10-15/May 17-21
Meeting Location:	Philadelphia, PA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2021-07-01
Language:	English
ACCESSION:	WOS:000680263501301
PROVIDER:	wos
DOI:	10.1158/1538-7445.AM2021-CT219
Notes:	Meeting Abstract: CT219 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/186843